ameCCNB1 PCRV frw SequenceGCT TCA CT and 3 more items

Integrated DNA Technologies Inc has been awarded a contract by Virginia Commonwealth University with an award date of August 3, 2026, for a cumulative value of $23.00. The contract involves the provision of polymerase chain reaction (PCR) sequencing products, specifically customized oligonucleotide sequences for molecular biology applications. The line items specify four distinct sequence products: two CCNB1 PCR variant sequences (forward and reverse) at $6.05 each, and two CDK4 PCR variant II sequences (forward and reverse) at $5.75 and $6.05 respectively. All deliverables are designated for delivery to VCU Procurement in Virginia.

The contract represents a procurement of research-grade molecular reagents required for genetic analysis or validation work at Virginia Commonwealth University. Each sequence variant is ordered in a quantity of one unit and represents standard components used in molecular biology research protocols. The minimal contract value and discrete nature of the line items indicate this is a specialized, limited-scope procurement supporting specific research initiatives at the Virginia institution.